Your session is about to expire
← Back to Search
Exoskeleton-Assisted Walking for Spinal Cord Injury (HIT Exo IP Trial)
HIT Exo IP Trial Summary
This trial will test if a wearable robotic exoskeleton can help people walk at a high intensity, which may improve their walking ability.
HIT Exo IP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHIT Exo IP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HIT Exo IP Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What objectives are being pursued with this research?
"The primary aims of this trial, as evaluated during session 5 (around day 11), is to measure the alterations in Self-Selected Gait Speed via a 10 Meter Walk Test. Secondary goals comprising of Modified Functional Reach Test for seated dynamic reach and GAITRite pressure map's temporal-spatial gait parameters such as double support percentage and stride length should also be observed."
Are patients being accepted into the trial at this time?
"Affirmative. According to the clinicaltrials.gov website, this clinical trial is recruiting participants as of now and was first posted on August 6th 2021. The last update occurred on January 5th 2022; 20 patients are needed from a single location for the study to reach completion."
What is the aggregate number of participants in this experiment?
"Affirmative. Clinicaltrials.gov evidences that the trial is presently recruiting participants, which were first mentioned on 8/6/2021 and most recently updated on 1/5/2022. Subsequently, 20 test subjects will be enrolled from one medical site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger